In vivo platelet function following cardiopulmonary bypass

Area of Science:

• Cardiovascular Surgery
• Hematology
• Transfusion Medicine

Background:

• Cardiopulmonary bypass (CPB) can affect platelet function, potentially leading to bleeding complications.
• Assessing in vivo platelet hemostatic function post-CPB is crucial for guiding transfusion strategies.

Purpose of the Study:

• To evaluate the in vivo hemostatic function of platelets in patients undergoing open-heart surgery after CPB.
• To determine the necessity of routine platelet transfusions in this patient population.

Main Methods:

• Template bleeding times (TBT) were measured pre-CPB, 3 hours post-CPB, and 18-20 hours postoperatively in 22 patients.
• The Harker-Slichter formula was used to adjust for thrombocytopenia when interpreting TBT.
• Patients received either standard care or only frozen erythrocyte transfusions.

Main Results:

• 91% of patients exhibited normal or shorter-than-expected TBT post-CPB.
• Patients with platelet counts below 100,000/cu mm often had TBT shorter than predicted.
• All patients receiving only frozen erythrocytes showed normal or shorter-than-predicted TBT.

Conclusions:

• In vivo platelet hemostatic function is generally preserved after cardiopulmonary bypass.
• Routine platelet transfusions are typically not required following open-heart surgery.
• Frozen erythrocyte transfusions alone are often adequate for managing blood loss in these procedures.